Yahoo Finance

Mitsubishi Tanabe Pharma Canada, Inc. Announces Publication of Long-Term Function and Survival Analysis of RADICAVA® Oral Suspension (edaravone) -Treated Patients with ALS

TORONTO, Sept. 4, 2025 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), today announced the publication of a retrospective ...
Morningstar

Mitsubishi Tanabe Pharma America Announces Publication of Long-Term Function and Survival Analysis of RADICAVA ORS® (edaravone)-Treated Patients with ALS

JERSEY CITY, N.J., Aug. 19, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of a retrospective analysis of patients living with amyotrophic lateral ...